We are testing a new treatment for people with refractory progressive forms of multiple sclerosis. The study aims to assess its safety and how well it may work.
Health conditions and diseases that the clinical trial is designed to study and treat.
Progressive Multiple Sclerosis is a type of multiple sclerosis that leads to a steady decline in function and symptoms over time, without periods of remission. It can be particularly challenging as it often does not respond well to standard treatments.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.